High- and moderate-intensity warfarin regimens did not differ for preventing thrombosis in the antiphospholipid antibody syndrome
- Venous thrombosis of the bladder associated with antiphospholipid syndrome. Brooks, M. D.; Fletcher, M. S.; Melcher, D. H. // Journal of the Royal Society of Medicine;Oct1994, Vol. 87 Issue 10, p633
The article presents the case of a Thai male diagnosed with bladder gangrene with thrombosed veins associated with primary antiphospholipid syndrome. It mentions the challenges in diagnosing bladder gangrene because cytoscopic findings can lead to impression of tumor while resuscitation and...
- Kidney transplantation without reversal of warfarin. Mudge, David W.; Campbell, Scott B.; Ray, Mark // NDT Plus;Apr2010, Vol. 3 Issue 2, p170
Some patients called for kidney transplantation are anticoagulated with warfarin for indications such as antiphospholipid syndrome, where the risk of thrombosis with reversal may be high. Traditionally, the approach has been reversal of warfarin and treatment perioperatively with intravenous...
- Uso de la heparina de bajo peso molecular y aspirina en una paciente con sÃndrome antifosfolÃpido y pÃ©rdida gestacional recurrente. Salazar Martínez, Hernando Augusto; Lancheros García, Eder Ariel; Becerra Mojica, Carlos Hernán // MedUNAB;dic2011-mar2012, Vol. 14 Issue 3, p188
Recurrent pregnancy lost (RPL) is a common condition that causes great impact on partners leading frustration, anxiety, depression, excessive spending and even breaks in the relationship. Its etiology is multifactorial and often cannot be determined. This paper describes a case of a patient who...
- High- and moderate-intensity warfarin regimens did not
differ for preventing thrombosis in the antiphospholipid antibody
syndrome: COMMENTARY. Eikelboom, John W. // ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p38
The article comments on a study conducted to compare the effectiveness of high-intensity and moderate-intensity of warfarin for preventing recurrent thrombosis. Patients with antiphospholipid antibodies who develop thrombosis are generally recommended to continue warfarin therapy indefinitely....
- Warfarin started at 10 mg achieves therapeutic INR faster than 5 mg. Cementina, Alan; Jackson, Eric A. // Journal of Family Practice;Sep2003, Vol. 52 Issue 9, p680
The article presents a study which compared 2 dosing nomograms that may facilitate initiation of warfarin in patients with confirmed acute venous thromboembolism. Patients were excluded if they had a baseline international normalized ratio (INR) greater than 1.4, recently received oral...
- Antiphospholipid antibody syndrome in a patient with neurosarcoidosis. Satti, S.D.; Bartholomew, J.; Gordon, S.M.; Longworth, D.L.; Ada, K.A.l. // Vascular Medicine;1999, Vol. 4 Issue 1, p37
The case of a 56-year-old woman who developed neurosarcoidosis and was discovered to have inferior vena cava and lower extremity thromboses is described. She was found to have anticardiolipin antibodies. This newly described association of antiphospholipid antibody syndrome with sarcoidosis is...
- Antiphospholipid Antibody Syndrome. // Review of Optometry;10/15/2002 Supplement, Vol. 139, p58A
Investigates the signs and symptoms of the antiphospholipid antibody syndrome. Attribution of thrombosis with resultant ischemia to the disease; Factors causing the disease; Management of the disease.
- Antiphospholipid syndrome. Khamashta, Munther A.; Hughes, Graham V. // BMJ: British Medical Journal (International Edition);10/9/93, Vol. 307 Issue 6909, p883
Analyzes the etiology and symptoms of antiphospholipid syndrome. Association of antiphospholipid syndrome with thrombosis; Clinical manifestations of the syndrome; Treatment of the autoimmune diseases.
- Researchers Uncover Culprits in Life-Threatening Clotting Disorder. // Trends in Applied Sciences Research;Jul2011, Vol. 6 Issue 7, p775
No abstract available.